Rimiterol
Top View
- Supplementary File
- Council of Europe Committee of Ministers (Partial
- Comparison Between a New Once-Daily, Bronchodilating Drug, Bambuterol, and Terbutaline Sustained-Release, Twice Daily
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Effect of Cessation of Short-Term Therapy with Ipratropium Bromide on Lung Function and Airway Responsiveness
- Statistical Analysis Plan
- (12) United States Patent (10) Patent No.: US 8,506,935 B2 Hale Et Al
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) Patent Application Publication (10) Pub. No.: US 2003/0005927 A1 Van Oort Et Al
- Study Protocols
- 2019 Equine Prohibited Substances List
- (12) United States Patent (10) Patent No.: US 6,455,028 B1 Wulfhart Et Al
- Review of the Square Box Symbol Uses
- Transdermal Device Containing
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- New Techniques Aerosol Delivery Systems for Bronchial Asthma
- Customs Tariff - Schedule Xxi - 1
- Delivered Byaerosol